<!DOCTYPE html><html><head><meta charSet="utf-8" class="next-head"/><title class="next-head">ALiEM Cards</title><meta name="viewport" content="initial-scale=1.0, width=device-width" class="next-head"/><meta charset="utf-8" class="next-head"/><meta http-equiv="x-ua-compatible" content="ie=edge" class="next-head"/><link rel="apple-touch-icon" sizes="180x180" href="/static/Favicons/apple-touch-icon.png" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-32x32.png" sizes="32x32" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-16x16.png" sizes="16x16" class="next-head"/><link rel="mask-icon" href="/static/Favicons/safari-pinned-tab.svg" color="#00b092" class="next-head"/><link rel="shortcut icon" href="/static/Favicons/favicon.ico" class="next-head"/><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans" class="next-head"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js" as="script"/><link rel="preload" href="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" as="script"/><link rel="preload" href="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" as="script"/><link rel="preload" href="/_next/static/chunks/styles.9b76ae77785496d5351a.js" as="script"/><link rel="preload" href="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" as="script"/><link rel="stylesheet" href="/_next/static/css/commons.b3e9c004.chunk.css"/><link rel="stylesheet" href="/_next/static/css/styles.0fc85b66.chunk.css"/></head><body><div id="__next"><div data-reactroot=""><div><div class="header" role="banner"><div class="header__logo"><a href="/"><img src="/static/logo.svg"/></a></div><div class="header__nav-button"><button class="hamburger hamburger__squeeze"><span class="hamburger__box"><span class="hamburger__inner"></span></span></button></div><nav class="header__nav header__nav--closed" role="navigation"><ul><li><a href="/cards/">Cards</a></li><li><a href="/categories/">Categories</a></li><li><a href="/about/">About</a></li></ul></nav></div><div class="search"><div class="search__input" role="search"><input type="text" placeholder="Search" aria-label="Search for cards" value=""/></div></div></div><main class="content container" role="main"><article role="article"><h1>Kawasaki Disease</h1><div class="card"><div class="card__meta"><div><strong>Author: </strong>Michelle Lin, MD</div><div><strong>Updated:</strong> <!-- -->3/23/2012</div></div><div class="card__content"><h1 id="kawasaki-disease">Kawasaki Disease</h1>
<h2 id="definition">Definition</h2>
<p>Acute, self-limited vasculitis of unknown etiology that occursmostly in infants and young children </p>
<h2 id="classic-clinical-criteria">Classic clinical criteria</h2>
<ol>
<li><strong>Fever for &ge; 5 days</strong>, AND</li>
<li><p>At least <strong>4</strong> of the 5 following:</p>
</li>
<li><p>Bilateral bulbar nonexudative conjunctivitis</p>
</li>
<li>Cervical lymphadenopathy (&gt; 1.5 cm diameter), usually unilateral</li>
<li>Changes in lips and oral cavity</li>
<li>Erythema<ul>
<li>Lip cracking</li>
<li>Strawberry tongue</li>
<li>Diffuse injection of oral/pharyngeal mucosae</li>
</ul>
</li>
<li>Changes in extremities<ul>
<li>Acute: Erythema of palms or soles; edema of hands or feet</li>
<li>Subacute: Periungual peeling of fingers or toes in weeks #2-3   </li>
</ul>
</li>
<li>Polymorphous rash</li>
</ol>
<p><img src="https://aliemcards.netlify.com/media/kawasaki_image-1.png" alt="Signs of Kawasaki Disease drawing"></p>
<h2 id="complications">Complications</h2>
<p>Coronary artery aneurysms/ ectasis</p>
<ul>
<li>Increases risk of AMI, sudden death, ischemic heart disease (15-25% if untreated, and 5% if treated)</li>
</ul>
<h2 id="differential-diagnosis">Differential Diagnosis</h2>
<ul>
<li>Viral infections (measles, adenovirus, enterovirus, EBV)</li>
<li>Scarlet fever</li>
<li>Staphylococcal scalded skin syndrome</li>
<li>Toxic shock syndrome</li>
<li>Bacterial cervical lymphadenitis</li>
<li>Drug hypersensitivity reaction</li>
<li>Stevens-Johnson syndrome</li>
<li>Juvenile rheumatoid arthritis</li>
<li>Rocky Mountain Spotted Fever</li>
<li>Leptospirosis</li>
<li>Mercury hypersensitivity reaction </li>
</ul>
<h2 id="guideline-evaluation-of-suspected-incomplete-kawasaki-disease">Guideline: Evaluation of suspected incomplete Kawasaki Disease</h2>
<p>2004 American Heart Association Guidelines </p>
<p><img src="https://aliemcards.netlify.com/media/kawasaki_image-2.png" alt="Kawasaki Disease clinical decision pathway"></p>
<p><strong>Figure Notes</strong></p>
<ol start="2">
<li>Infants &le;6 months old on day &ge;7 of fever without other explanation should undergo lab testing and, if evidence of systemic inflammation is found, an echocardiogram, even if they have no clinical criteria</li>
<li>Check for classic findings</li>
<li><p>Supplemental lab criteria</p>
</li>
<li><p>Albumin &le;3.0 g/dL</p>
</li>
<li>Anemia for age</li>
<li>Elevation of ALT</li>
<li>Platelets after 7 d &ge;450,000/mm3</li>
<li>WBC &ge;15,000/mm3</li>
<li><p>Urine &ge;10 WBC/hpf</p>
</li>
<li><p>Can treat before performing echocardiogram</p>
</li>
<li><p>Echo is considered positive for purposes of this algorithm, if any of 3 conditions met: </p>
</li>
<li><p>Z score of LAD or RCA &ge;2.5</p>
</li>
<li>Coronary arteries meet Japanese Ministry of Health criteria for aneurysms </li>
<li><p>&ge;3 other suggestive features exist including:</p>
<ul>
<li>Perivascular brightness</li>
<li>Lack of tapering</li>
<li>Decreased LV function</li>
<li>Mitral regurgitation</li>
<li>Pericardial effusion</li>
<li>z score of LAD or RCA is 2–2.5</li>
</ul>
</li>
<li><p>If echo is positive, treatment should be given to children within 10 days of fever onset and those beyond day 10 with clinical and lab signs of ongoing inflammation (CRP, ESR).</p>
</li>
<li>Typical peeling begins under nail bed of fingers and then toes.</li>
</ol>
<h2 id="references">References</h2>
<ul>
<li>Newburger JW et. al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. <em>Circulation</em>. 2004 Oct 26;110(17):2747-71. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=15505111">PubMed</a>]</li>
</ul>
</div></div></article></main><div class="footer" role="contentinfo"><div class="container"><div class="row footer__cc"><div class="footer__cc-image"><a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><img alt="creative-commons" src="/static/by-nc-nd.svg"/></a></div><div class="footer__cc-text">This work is licensed under a<!-- --> <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License</a>.</div></div><div class="row footer__links"><div><a href="/contact/">Contact</a></div><div><a href="/contact/">Get Involved</a></div><div><a href="/about/">About</a></div></div><div class="row row--centered"><div class="container footer__disclaimer">ALiEM Cards content is intended for use by healthcare professionals. Users of this site should exercise their own clinical judgment as to the reliability and accuracy of its information. Non-healthcare-professionals who use this site do so at their own risk. Content on this site should not be construed as medical advice. Users should always confer with medical profoessionals regarding decisions about medications, evaluations and other medical treatments.</div></div></div></div></div></div><script>__NEXT_DATA__ = {"props":{"pageProps":{"card":{"slug":"kawasaki","title":"Kawasaki Disease","authors":["Michelle Lin, MD"],"categories":[{"slug":"pediatrics","name":"Pediatrics"},{"slug":"cardiovascular","name":"Cardiovascular"}],"created":"2012/03/23","updated":null,"body":"\n# Kawasaki Disease\n\n## Definition \nAcute, self-limited vasculitis of unknown etiology that occursmostly in infants and young children \n\n## Classic clinical criteria\n\n1. **Fever for \u0026ge; 5 days**, AND\n2. At least **4** of the 5 following:\n\n- Bilateral bulbar nonexudative conjunctivitis\n- Cervical lymphadenopathy (\u003e 1.5 cm diameter), usually unilateral\n- Changes in lips and oral cavity\n- Erythema\n  - Lip cracking\n  - Strawberry tongue\n  - Diffuse injection of oral/pharyngeal mucosae\n- Changes in extremities\n  - Acute: Erythema of palms or soles; edema of hands or feet\n  - Subacute: Periungual peeling of fingers or toes in weeks #2-3   \n- Polymorphous rash\n\n![Signs of Kawasaki Disease drawing](https://aliemcards.netlify.com/media/kawasaki_image-1.png)\n\n## Complications\nCoronary artery aneurysms/ ectasis\n- Increases risk of AMI, sudden death, ischemic heart disease (15-25% if untreated, and 5% if treated)\n\n## Differential Diagnosis\n\n- Viral infections (measles, adenovirus, enterovirus, EBV)\n- Scarlet fever\n- Staphylococcal scalded skin syndrome\n- Toxic shock syndrome\n- Bacterial cervical lymphadenitis\n- Drug hypersensitivity reaction\n- Stevens-Johnson syndrome\n- Juvenile rheumatoid arthritis\n- Rocky Mountain Spotted Fever\n- Leptospirosis\n- Mercury hypersensitivity reaction \n\n## Guideline: Evaluation of suspected incomplete Kawasaki Disease\n\n2004 American Heart Association Guidelines \n\n![Kawasaki Disease clinical decision pathway](https://aliemcards.netlify.com/media/kawasaki_image-2.png)\n\n**Figure Notes**\n\n2. Infants \u0026le;6 months old on day \u0026ge;7 of fever without other explanation should undergo lab testing and, if evidence of systemic inflammation is found, an echocardiogram, even if they have no clinical criteria\n3. Check for classic findings\n4. Supplemental lab criteria\n\n- Albumin \u0026le;3.0 g/dL\n- Anemia for age\n- Elevation of ALT\n- Platelets after 7 d \u0026ge;450,000/mm3\n- WBC \u0026ge;15,000/mm3\n- Urine \u0026ge;10 WBC/hpf\n\n5. Can treat before performing echocardiogram\n6. Echo is considered positive for purposes of this algorithm, if any of 3 conditions met: \n\n- Z score of LAD or RCA \u0026ge;2.5\n- Coronary arteries meet Japanese Ministry of Health criteria for aneurysms \n- \u0026ge;3 other suggestive features exist including:\n  - Perivascular brightness\n  - Lack of tapering\n  - Decreased LV function\n  - Mitral regurgitation\n  - Pericardial effusion\n  - z score of LAD or RCA is 2–2.5\n\n7. If echo is positive, treatment should be given to children within 10 days of fever onset and those beyond day 10 with clinical and lab signs of ongoing inflammation (CRP, ESR).\n8. Typical peeling begins under nail bed of fingers and then toes.\n\n## References\n\n- Newburger JW et. al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. _Circulation_. 2004 Oct 26;110(17):2747-71. [[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/?term=15505111)]\n"}}},"page":"/card","pathname":"/card","query":{"slug":"kawasaki"},"buildId":"1~ee3OFOv6kXxZUoU_eCb","nextExport":true};__NEXT_LOADED_PAGES__=[];__NEXT_REGISTER_PAGE=function(r,f){__NEXT_LOADED_PAGES__.push([r, f])}</script><script async="" id="__NEXT_PAGE__/card" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js"></script><script async="" id="__NEXT_PAGE__/_app" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js"></script><script async="" id="__NEXT_PAGE__/_error" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js"></script><script src="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" async=""></script><script src="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" async=""></script><script src="/_next/static/chunks/styles.9b76ae77785496d5351a.js" async=""></script><script src="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" async=""></script></body></html>